Cibc Private Wealth Group, LLC Cytokinetics Inc Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,708 shares of CYTK stock, worth $102,531. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,708
Previous 1,653
3.33%
Holding current value
$102,531
Previous $77,000
11.69%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CYTK
# of Institutions
388Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.06 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$881 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$719 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$470 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$383 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.65B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...